These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18456421)

  • 1. [Do anticoagulants improve survival in patients with cancer?].
    Meyer G
    Pathol Biol (Paris); 2008 Jun; 56(4):233-8. PubMed ID: 18456421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does antithrombotic therapy improve survival in cancer patients?
    Cunningham MS; Preston RJ; O'Donnell JS
    Blood Rev; 2009 May; 23(3):129-35. PubMed ID: 19046797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer.
    Lee AY
    Thromb Res; 2007; 120 Suppl 2():S121-7. PubMed ID: 18023705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy and survival in cancer patients.
    Kakkar AK
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):147-51. PubMed ID: 19285281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.
    ten Cate-Hoek AJ; Prins MH
    Thromb Res; 2008; 122(5):584-98. PubMed ID: 17996281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies.
    Lecumberri R; Páramo JA; Rocha E
    Haematologica; 2005 Sep; 90(9):1258-66. PubMed ID: 16154849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heparin and cancer].
    Lykke J
    Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies with anticoagulants to improve survival in cancer patients.
    Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
    Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated venous thrombosis in the surgical setting.
    Behranwala KA; Williamson RC
    Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence.
    Mousa SA; Petersen LJ
    Thromb Haemost; 2009 Aug; 102(2):258-67. PubMed ID: 19652876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.
    Noble SI; Hood K; Finlay IG
    Palliat Med; 2007 Sep; 21(6):473-6. PubMed ID: 17846086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotics in thrombosis and cancer.
    Mousa SA
    Hamostaseologie; 2005 Nov; 25(4):380-6. PubMed ID: 16395488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin in thrombosis and cancer.
    Mousa SA
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():25-30. PubMed ID: 15085463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
    Pruemer J
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotics in thrombosis and cancer.
    Mousa SA
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):283-91. PubMed ID: 15030287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence.
    Cosgrove RH; Zacharski LR; Racine E; Andersen JC
    Semin Thromb Hemost; 2002 Feb; 28(1):79-87. PubMed ID: 11885028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulants and cancer survival.
    Piccioli A; Falanga A; Prandoni P
    Semin Thromb Hemost; 2006 Nov; 32(8):810-3. PubMed ID: 17171594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cytokine and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular weight heparin administration.
    Di Nisio M; Niers TM; Reitsma PH; Buller HR
    Cancer; 2005 Nov; 104(10):2275-81. PubMed ID: 16216004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.